Taro Pharmaceutical Industries Ltd. announced the appointment of Daphne Huang as Vice President, CFO and Chief Accounting Officer, effective April 6, 2020. Ms. Huang has over 20 years of senior executive experience in finance; most recently serving as Chief Financial Officer at Humanwell Healthcare USA & Puracap International, having financial oversight of their generic pharmaceutical and OTC portfolios.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.3 USD | -0.26% | -0.35% | +1.24% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.24% | 1.59B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- TARO Stock
- News Taro Pharmaceutical Industries Ltd.
- Taro Pharmaceutical Industries Ltd. Appoints Daphne Huang as Vice President, CFO and Chief Accounting Officer, Effective April 6, 2020